Thin Margins Challenge Cash Flow Value
UndervaluedDCF
Equity analysis

Cardinal Health Inc (CAH) Thin Margins Challenge Cash Flow Value

May 10, 2026Equity Analysis

Is the price discounting more value than thin margins can deliver?

Trailing P/E
27.66
Price
183.65
ROE
37.17
Gross Margin
3.76

How Does This Health Distributor Operate?

Cardinal Health is a large health care company focused on distributing pharmaceuticals and medical products. It sits in the middle of the supply chain, moving high volumes of product to pharmacies, hospitals, and other care providers. The business is built around scale and logistics, with revenue tied to the flow of medicines and medical supplies rather than a single flagship product. At today’s size, it is a major public company with a market value around USD 43 billion.

Are Margins and Returns Holding Steady?

Fundamentals

For the year ended June 30, 2025 (reported in USD), revenue was USD 222.6 billion, down 1.9% versus the prior year. The cost structure remains tight: trailing gross margin is 3.76%, operating margin 0.92%, and net profit margin 0.62%, showing how much the model depends on volume and efficiency.

On capital-related measures, trailing ROE is 37.17%, while a return-on-invested-capital proxy is 4.44%. Depreciation and amortization totaled USD 790 million, and total debt stood at USD 550 million.

Is The Market Undervaluing Cash Flows?

DCF / Multiples

At USD 183.65, the stock trades below the discounted cash flow range implied by the model, even under the weaker scenario. The market’s current multiples—27.66x trailing earnings and 17.76x EV/EBITDA—coexist with a cash‑flow‑based valuation that still points higher than the present share price.

Efficiency Must Stay Intact

Takeaway

The valuation is already leaning on cash flows holding up. That only works if returns on capital stay resilient. With margins this thin, small slippage can matter quickly. If capital efficiency fades, the gap to fair value can close fast.

Disclaimer
This analysis is for informational purposes only and does not constitute investment advice.
Fair Value Rankings

Market Price vs Intrinsic Value

Quick access to the most undervalued and overvalued stocks, ranked by their discount or premium to DCF-based fair value.

Undervalued

Stocks trading below fair value

View full ranking
1
Delta Air Lines Inc
DAL
+80%
discount
2
Brown & Brown Inc
BRO
+79%
discount
3
Verizon Communications Inc
VZ
+78%
discount
Overvalued

Stocks trading above fair value

View full ranking
1
Bank of America Corp
BAC
+393%
premium
2
Applied Materials Inc
AMAT
+392%
premium
3
Guidewire Software Inc
GWRE
+391%
premium
INDEX
VDIX
ValueDetect Intrinsic eXpectations Index
Overvalued market
View index

VDIX measures whether the market is expensive or cheap relative to intrinsic value. For each company, ValueDetect estimates fair value using a discounted cash flow (DCF) model, then compares it with the current share price to derive a RiskRatio. These signals are capped, weighted by market capitalization, and aggregated into a single market-wide score.

Current score-0.82Negative = market trades above fair value
1-day move-0.13Rising score = improving valuation conditions
7-day average-0.68Smoothed market valuation signal
Latest observation03 June 2026The latest weighted reading suggests that the market is trading above DCF-based intrinsic value in aggregate.
Next actions

What would you like?

Continuously expanding company coverage — prioritized by user demand.

Suggest a company to analyze

Help shape what we analyze next.

We'll send a confirmation email to verify your request — not for marketing.

New analyses are added regularly. Request processing times may vary.